Poster will characterize the efficacy of PIKTOR as a monotherapy and in combination with fulvestrant, oral SERDs, and CDK inhibitors in preclinical models of breast cancer; Poster ...
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier ...
Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany. Paris and Frankfurt, October 19, 2026 ...
In this newly created executive role, Ms. Roberson will lead the company's global talent and organizational strategy, with a ...
Quanta Therapeutics, a privately held, clinical-stage biopharmaceutical company leading the development of innovative ...
Collaboration spans Copper-67 supply and radiopharmaceutical manufacturing from clinical development through ...
Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ...
Partnership with Vanderbilt University and Vanderbilt Health accelerates development of the first radiomics-based test for ...
Three-year data from the EVX-01 phase 2 trial in patients with advanced melanoma to be presented at the ESMO 2026 Congress; ...
Disc Medicine’s bitopertin—rejected by the FDA in February—significantly reduced levels of a key disease biomarker and ...
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a ...
Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results